In the States

Select a state to learn more

State Activity

The Alliance for Safe Biologic Medicines was organized to serve as an authoritative resource center of information for the general public, as well as the healthcare and health policy communities, on the issues surrounding biologic medications.

Each state will be considering or introducing legislation to address what an FDA determination on interchangeability will mean for state substitution policies.  While the ultimate goal is to find a balance between producing economical drugs and respecting the drug-discovery process, patient safety should be paramount.

We are particularly concerned about how state laws and regulations will impact the doctor-patient relationship. Doctors and patients should be able to carefully choose the best course of treatment rather than have legislators and regulators decide for them. The path state governments decide to pursue in approving biosimilars should reinforce this principle.

As such, a number of local organizations have joined together to ensure that state biosimilar interchangeability and substitution issues are not implemented in ways that negatively impact patient care or the role of the physician in that process.

Please check back for more information on our membership and activities.

  • Archive

    Bio Nebraska: Bagels and Bio

    July 13, 2011

    July 27, 2011 Omaha, NE Read More

    Omaha Science Cafe

    July 13, 2011

    June 7, 2011 The Slowdown, 729 North 14th Street Omaha, NE Read More

    July 13, 2011

    Bio Nebraska Life Sciences Association Nebraska Department of Health and Human Services Nebraska Medical Association Nebraska State Legislature Nebraska State Senate Office of Governor Dave Heineman University of Nebraska-Lincoln – Center for Biotechnology

    The State of Biosciences in Nebraska

    July 13, 2011

    Nebraska’s bioscience industry has a specialized employment concentration and is growing. The state has employment specializations in two of the four major subsectors – agricultural feedstock and chemicals and medical devices and equipment. Academic bioscience research and development expenditures totaled $251 million in 2008, led by biological sciences ($114 million) followed by medical sciences ($70 […]

    Governor’s Bioscience Award Presented at Bio Nebraska Annual Meeting

    July 13, 2011

    Bio Nebraska Life Sciences Association celebrated a successful year at their 2011 Annual Meeting on April 14, 2011. The meeting was held at the University of Nebraska-Lincoln’s Whittier Research Center, 2200 Vine Street, in Lincoln. Read More

    Nebraska Bioscience and Medical Technologies Brochure

    July 13, 2011

    Nebraska offers a research and development tax credit, tax incentives and a business relationship with some of Nebraska’s cutting edge bioscience centers, institutes, and programs. Read More

    Nebraska Bioscience Roadmap

    July 13, 2011

    Bio Nebraska presented the Nebraska Bioscience Roadmap to members and friends at their Fifth Anniversary Celebration. The Roadmap was a partnership between the Nebraska Legislature Natural Resources Committee and Bio Nebraska and represents a five-year strategy to grow the bioscience industry in Nebraska. Read More